Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-3112 in HPV-positive cervical cancer
NCT02172911Phase 2Completed
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Jun 2014
- Primary completion
- Sep 2017
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MEDI0457 in Cervical Cancer (CC), sponsored by Inovio Pharmaceuticals, Inc.. Started Jun 2014; status: completed.
02
Drugs
MEDI0457
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02172911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172911.